Ergomed’s Solutions to the Challenges of Oncology Trials

See how Ergomed’s Phase III Clinical Trial for Locally Advanced Squamous Cell Head & Neck Carcinoma (SCCHN) tackled one of the largest head and neck cancer studies globally.

 
With 928 patients across 120+ sites in North America, Europe, and Asia, this Rescue study faced challenges in enrollment, complex site coordination, and integrating diverse standards of care. Discover how Ergomed’s Site Management and Study Physician Support services expanded site reach, enhanced recruitment, and fostered multidisciplinary collaboration across departments. With a 560% patient enrollment increase and significant clinical outcomes, download the full case study to learn how Ergomed drives success in global oncology research.  

"*" indicates required fields

Please enter your details to get access to the resource

By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.
This field is for validation purposes and should be left unchanged.